Condition

Glucose Metabolism Disorders

ClinicalTrials.gov condition label

Clinical trials104

Recruiting10

Common interventions25

Lead sponsors shown15

Clinical trials

60 shown

METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D)NCT07699380 · 2026-09-01

A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes Who Observe Ramadan FastingNCT07613307 · 2026-07-15

Inhaled Insulin vs Rapid-acting Injections for Post-meal Glucose Control in Women With Gestational DiabetesNCT06535789 · 2025-05-01

Clinical Trial Assessing Human Placental Membrane Products and Standard of Care Versus Standard of Care in Nonhealing DFUs and VLUsNCT06674980 · 2024-12-20

Continuous Glucose Monitoring Glycemic cHAracterization During PregnancyNCT06357728 · 2024-07-01

Relationship Between Individual Effect of Diet on Postprandial Glycemia and Gut Microbiome Profile in Healthy SubjectsNCT06051318 · 2024-06-06

Cognitive-Behavioral Therapy and Exercise Training in Adolescents At-Risk for Type 2 DiabetesNCT05543083 · 2023-06-02

Rare and Atypical Diabetes NetworkNCT05544266 · 2020-09-30

RT-CGM in Young Adults at Risk of DKANCT04039763 · 2020-09-03

Regulation of Endogenous Glucose Production by Central KATP ChannelsNCT03540758 · 2018-08-01

Specificities of Atypical Non AutoImmune Diabetes (ANAID) in the French West IndiesNCT07576374 · 2026-06-01

NOT_YET_RECRUITING

The CGM-OGTT Glycemic Homeostasis StudyNCT07288372 · 2025-12-18

NOT_YET_RECRUITING

Financial Navigation and Peer Support to Improve Diabetes OutcomesNCT06619834 · 2025-02-11

In-Person Lifestyle Program for Black Adolescent Girls at Risk for Type 2 DiabetesNCT06557317 · 2024-08-01

Henagliflozin's Impact on Prediabetes RemissionNCT06448130 · 2024-06-01

NOT_YET_RECRUITING

Evaluating the Efficacy and Safety of Empagliflozin Addition to Insulin and Oral Antidiabetic Medication (OAD) Regimen in Poorly Controlled Type 2 Diabetes and Obese PatientNCT06145360 · 2023-12-01

Group Education Trial to Improve Transition for Parents of Adolescents With T1DNCT05445284 · 2023-10-10

Predicting Dysglycemia in Individuals With Gestational Diabetes Immediately Postpartum Using Continuous Glucose MonitoringNCT04972955 · 2023-07-04

ACTIVE_NOT_RECRUITING

Analysis of Volatile Organic Compounds in Patients With Type 1 Diabetes in Induced Hypoglycaemia With a Breath AnalyserNCT05933616 · 2023-04-20

Efficacy and Safety of Android Artificial Pancreas System in Adult Patients With Type 1 Diabetes Mellitus in ChinaNCT05726461 · 2023-02-11

A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 DiabetesNCT05691712 · 2023-02-05

An Open-Label, FIH Study Evaluating the Safety, Tolerability, and Efficacy of VCTX211 Combination Product in Subjects With T1DNCT05565248 · 2023-01-20

Bone Properties Following Exercise Induced Changes in Insulin Sensitivity in People With Type 2 DiabetesNCT06668090 · 2022-12-15

Dietary Counseling Coupled With FMT in the Treatment of Obesity and NAFLD - the DIFTOB StudyNCT05607745 · 2022-10-30

ACTIVE_NOT_RECRUITING

The Efficacy and Safety of DWP16001 in Combination With Metformin in T2DM Patients Inadequately Controlled on MetforminNCT05505994 · 2022-09-28

A Study to Evaluate Tirzepatide (LY3298176) in Pediatric and Adolescent Participants With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin or Basal Insulin or BothNCT05260021 · 2022-04-13

Metabolic Effects of Oral Sodium Butyrate Supplementation on Overweight IndividualsNCT06247020 · 2022-02-24

Digital Foot Self-Management Program for Older-DiabetesNCT05272670 · 2022-02-15

Energy Metabolism and Acute Effects of Protein Diets in Metabolically Obese Normal Weight IndividualsNCT06802341 · 2022-02-01

ACTIVE_NOT_RECRUITING

An Open-Label, FIH Study Evaluating the Safety and Tolerability of VCTX210A Combination Product in Subjects With T1DNCT05210530 · 2022-01-24

Glucose Homeostasis and Apple PolyphenolsNCT05951270 · 2022-01-14

Different Initial Insulin Dose Regimens on Time to Achieve Glycemic Targets and Treatment Safety in SIITNCT05084079 · 2021-11-01

Safety and Feasibility of Novel Therapy for Duodenal Mucosal Regeneration for Type II DiabetesNCT05014204 · 2021-10-29

Integrated Hyperglycaemia Incentivised Postnatal Surveillance Study (I-HIPS)NCT05081037 · 2021-09-06

ACTIVE_NOT_RECRUITING

Closed-loop Insulin Delivery In Type 1 Diabetes Pregnancies (CIRCUIT)NCT04902378 · 2021-06-15

A Study of Two Doses of Dulaglutide (LY2189265) in Japanese Patients With Type 2 DiabetesNCT04809220 · 2021-04-13

Effects of Glucose Lowering Agents in South Asian Women With Impaired Glucose Tolerance or Impaired Fasting GlucoseNCT04662866 · 2021-02-10

Efficacy and Safety of 12-weeks Supplementation of Eubacterium Hallii on Insulin Sensitivity and Glycaemic ControlNCT04529473 · 2021-02-03

Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients With Established COVID-19NCT04371978 · 2020-10-01

Assessment of Progranulin and FAM19A5 Protein Blood Levels in Metabolic SyndromeNCT04451616 · 2020-07-03

Assessing the Impact of the COVID-19 Lockdown on Metabolic Control and Access to Health Care in Patients With DiabetesNCT04485351 · 2020-07-01

Development of Continuous Glucose Monitoring System Cohort for Personalized Diabetes Prevention and Management PlatformNCT04369833 · 2020-05-11

Effect of Meal Texture on Glucose-metabolism and Gut Hormone Response After Bariatric SurgeryNCT04082923 · 2019-10-03

The Effect of Rapid and Slow Glucose Fall on the Subsequent Glucose Production in People With Type 1 DiabetesNCT04098549 · 2019-09-12

Phthalates Exposure in Type 2 Diabetic Patients and Diuretic TherapyNCT04242758 · 2019-06-04

The Influence of Overfeeding Different Macronutrients on Whole-body Insulin SensitivityNCT03863431 · 2019-05-22

The Role of Hepatic Denervation in the Dysregulation of Glucose Metabolism in Liver Transplant RecipientsNCT03685773 · 2019-04-21

The Effect of Water Intake on Glucose RegulationNCT03765008 · 2019-02-11

Bisphenol A and Muscle Insulin SensitivityNCT03771066 · 2019-01-01

Diabetes, Exercise and Liver Fat (DELIVER)NCT04004273 · 2018-10-30

The Dietary Education Trial in Carbohydrate Counting (DIET-CARB Study in Type 1 DiabetesNCT03623113 · 2018-09-28

Effects of Basic Carbohydrate Counting Versus Standard Outpatient Nutritional Education in Type 2 DiabetesNCT03623139 · 2018-09-28

Azithromycin Insulin Diet Intervention Trial in Type 1 DiabetesNCT03682640 · 2018-09-01

Effects on Glucose Homeostasis of Changes in Plasma Lipoproteins Induced by Nutritional and Pharmacologic StrategiesNCT05213988 · 2018-07-30

Effects of Simulated Passive Jogging Device on Glucose Homeostasis, Muscle Strength and EnduranceNCT03550105 · 2018-06-05

Soluble Epoxide Hydrolase Inhibition and Insulin ResistanceNCT03486223 · 2018-05-17

Low-intensity Exercise in Metabolic SyndromeNCT04346836 · 2018-05-06

Dietary Interventions on Glycocalyx Dimensions in South Asian Patients With Diabetic Nephropathy.NCT03889236 · 2018-05-03

Investigating Genetic Risk for Type 1 DiabetesNCT03503747 · 2018-04-25

Diamyd Administered Into Lymph Nodes in Combination With Vitamin D in Type 1 DiabetesNCT03345004 · 2017-12-20

Common interventions

Leading sponsors

Pfizer5 Eli Lilly and Company4 University of Cambridge4 Steno Diabetes Center Copenhagen3 Albert Einstein College of Medicine2 CRISPR Therapeutics AG2 Jaeb Center for Health Research2 KK Women's and Children's Hospital2 Singapore Institute of Food and Biotechnology Innovation2 Sun Yat-sen University2 University of Eastern Finland2 University of Pisa2 Vanderbilt University Medical Center2 Aarhus University Hospital1 Arizona State University1

Trial status mix

COMPLETED59

UNKNOWN19

RECRUITING10

ACTIVE_NOT_RECRUITING6

TERMINATED5

NOT_YET_RECRUITING3

WITHDRAWN2

Phase mix

NA50

PHASE212

PHASE310

PHASE19

PHASE48

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.